Oral and Palmitate Paliperidone Long-Acting Injectable Formulations’ Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP)

BACKGROUND: Long-acting injectable antipsychotics (LAIs) may be a suitable therapeutic option for those patients in earlier stages of psychosis to avoid relapses and disease progression. Despite that, there is a lack of evidence in the literature regarding the use of LAIs in this profile of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Segarra, R, Recio-Barbero, M, Sáenz-Herrero, M, Mentxaka, O, Cabezas-Garduño, J, Eguíluz, J I, Callado, L F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453287/
https://www.ncbi.nlm.nih.gov/pubmed/34009370
http://dx.doi.org/10.1093/ijnp/pyab021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453287/
https://www.ncbi.nlm.nih.gov/pubmed/34009370
http://dx.doi.org/10.1093/ijnp/pyab021

Ejemplares similares